ACEMETACIN

DRUG2 trials

Sponsors

Cannaxan GmbH, Apurano Pharmaceuticals GmbH, St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr

Conditions

Axial SpondyloarthritisChronic back pain

Phase 3

Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain

SuspendedCTIS2022-502151-54-00

Cannaxan GmbH, Apurano Pharmaceuticals GmbHChronic back pain

Start: 2023-11-02Target: 558Updated: 2024-11-22

Phase 4

Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis

RecruitingCTIS2024-513213-13-00

St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-RuhrAxial Spondyloarthritis

Start: 2025-03-13Target: 100Updated: 2025-09-06